Larimar Therapeutics (LRMR) Non-Current Debt: 2014-2020
Historic Non-Current Debt for Larimar Therapeutics (LRMR) over the last 5 years, with Mar 2020 value amounting to $6.7 million.
- Larimar Therapeutics' Non-Current Debt fell 50.12% to $6.7 million in Q1 2020 from the same period last year, while for Mar 2020 it was $6.7 million, marking a year-over-year decrease of 50.12%. This contributed to the annual value of $8.5 million for FY2019, which is 44.26% down from last year.
- Per Larimar Therapeutics' latest filing, its Non-Current Debt stood at $6.7 million for Q1 2020, which was down 20.29% from $8.5 million recorded in Q4 2019.
- In the past 5 years, Larimar Therapeutics' Non-Current Debt registered a high of $20.2 million during Q1 2018, and its lowest value of $1.2 million during Q3 2016.
- In the last 3 years, Larimar Therapeutics' Non-Current Debt had a median value of $13.5 million in 2019 and averaged $13.5 million.
- Data for Larimar Therapeutics' Non-Current Debt shows a maximum YoY plummeted of 71.17% (in 2016) over the last 5 years.
- Over the past 5 years, Larimar Therapeutics' Non-Current Debt (Quarterly) stood at $1.2 million in 2016, then reached $20.0 million in 2017, then fell by 24.08% to $15.2 million in 2018, then tumbled by 44.26% to $8.5 million in 2019, then plummeted by 50.12% to $6.7 million in 2020.
- Its Non-Current Debt was $6.7 million in Q1 2020, compared to $8.5 million in Q4 2019 and $10.2 million in Q3 2019.